Experts now want to find out if the technology can help people with diabetes, of all ages, to effectively control their condition, in a real-world setting.
This article outlines the new NICE recommendations on continuous glucose monitoring in adults with type 2 diabetes, as well as the recommendations’ rationale and possible impact on clinical practice.
This article outlines the new NICE recommendations on continuous glucose monitoring in children and young people with diabetes, as well as the recommendations’ rationale and possible impact on clinical practice.
This article outlines the new NICE recommendations on continuous glucose monitoring in adults with type 1 diabetes, as well as the recommendations’ rationale and possible impact on clinical practice.
Following the latest NICE advice, more than 250,000 people living with type 1 diabetes are set to be offered new technology to help them manage their condition. Use of flash monitoring is also extended to adults with type 2 diabetes on insulin therapy.
The authorisation holder for dapagliflozin has withdrawn the indication for type 1 diabetes mellitus. The removal of the type 1 diabetes indication is not due to any new safety concerns and the other indications of dapagliflozin are unchanged.
We and selected partners, use cookies or similar technologies as specified in the cookie policy and privacy policy.
You can consent to the use of such technologies by closing this notice.
Cookie Control
Customise your preferences for any tracking technology
The following allows you to customize your consent preferences for any tracking technology used
to help us achieve the features and activities described below. To learn more about how these trackers help us
and how they work, refer to the cookie policy. You may review and change your preferences at any time.
These trackers are used for activities that are strictly necessary to operate or deliver the service you requested from us and, therefore, do not require you to consent.
These trackers help us to provide a personalized user experience by improving the quality of your preference management options, and by enabling the interaction with external networks and platforms.
Please sign in or register for FREE
Sign in to OnMedica
Membership worth £180/year - free for UK physicians
Join OnMedica today and benefit from:
Bitesize CPD and easy to digest content, free for UK-based GPs and specialist doctors
High-quality, evidence-based content developed by expert editors and clinicians
Articles, quizzes, videos, visual summaries and more
Regulatory alerts and round-up of medical journals
New content added daily, so you know you’re always up to date
See what other members have to say:
"Very useful, I have filled many gaps and gained practical knowledge."
"I feel now more confident in diagnosing the presented conditions. Really it is one of the best learning activities I have completed recently."